ArticleClinical kidney journal2022
Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review.
Alexandra Gallagher et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.